CARMN and invasive ductal breast carcinoma: In GSE21422, CARMN in ductal carcinoma in situ (DCIS) was lower than that in normal breast tissue and was obviously higher than that in invasive ductal carcinoma (IDC) at the same time (Fig. 1E).